Explore more topics
SEC Form 4 research

Adaptimmune Therapeutics PLC insider transactions

Inspect Adaptimmune Therapeutics PLC's public SEC insider acquisitions and sales, reporting owners and source receipts.

As of 2026-10-15T08:02:39.132Z

Issuer CIK
0001621227
Reporting owners
45
Officers and directors
16
Jump to a section

What is a Form 4?

Animation: what a Form 4 is, shown with one real example. Sonic Automotive (SAH) reporting owner Paul P. Rusnak bought 13,701 shares at $59.78 on Wednesday, October 7, 2026, transaction code P, an open-market purchase (S is a sale and A is an award from the company). A timeline marks the SEC's two-business-day filing deadline, which ends Friday, October 9. The SEC accepted the Form 4 at 4:33:21 PM ET on October 9, and NexusTrade treats it as public one minute later, at 4:34:21 PM ET. A lamp for NexusTrade's InsiderTrades indicator stays off from the trade date until that moment, then counts one purchase worth 13,701 × $59.78 = $819,045.78.
In this example the shares were bought on Oct 7, 2026, and NexusTrade's InsiderTrades indicator can count the purchase starting at 4:34:21 PM ET on Oct 9, one minute after the SEC accepted the Form 4.

A Form 4 is the SEC filing a company insider, such as an officer, director or 10% owner, uses to report a trade in the company's stock, generally within two business days. The animation follows one real filing as an example: Paul P. Rusnak's purchase of Sonic Automotive (SAH) shares on October 7, 2026.

The same reading applies to every row on this page. The trade date is when the shares changed hands. The available date is when NexusTrade treats the filing as public, and a NexusTrade InsiderTrades indicator counts a purchase (code P) or sale (code S) only from that moment. Code A awards are not counted as purchases.

Recent insider disclosures

This table includes purchases, sales and awards in the public filing record. Awards and open-market purchases are distinct transaction codes. For historical research, use the public availability date to determine when the transaction was knowable.

Read code P as a purchase, S as a sale and A as an award. An award is an acquisition, but it is not an open-market purchase. Open the filing receipt to check the transaction details.

Show the table · 0 rows, 7 columns

Scroll sideways to compare all columns. Select a heading to sort.

No records are available for this view.

Most recent 90-day source activity, up to 50 rows. No rows means no matching recent records, not no historical activity.

Officers and directors in the directory

Show the table · 17 rows, 3 columns

Scroll sideways to compare all columns. Select a heading to sort.

MOTT DAVID M0001219871144
Sigal Charles Elliott00016619088
Thompson Peter A.0001357522111
Menzel Garry E00015560649
Alleva Lawrence M000155305322
OrbiMed Capital GP V LLC0001615374113
Behbahani Ali000161386738
Wood Gavin00015775398
Amado Rafael000166211911
Bertrand William C JR000129193726
Binder-Scholl Gwendolyn Knowlton00016621161
ISALY SAMUEL D0001055949417
Lunger John000178448728
Norry Elliot000179811721
ORBIMED ADVISORS LLC00010559511,020
Piccina Cintia00019071994
Rawcliffe Adrian000155585134
MOTT DAVID M ↗Sigal Charles Elliott ↗Thompson Peter A. ↗Menzel Garry E ↗Alleva Lawrence M ↗OrbiMed Capital GP V LLC ↗Behbahani Ali ↗Wood Gavin ↗Amado Rafael ↗Bertrand William C JR ↗Binder-Scholl Gwendolyn Knowlton ↗ISALY SAMUEL D ↗Lunger John ↗Norry Elliot ↗ORBIMED ADVISORS LLC ↗Piccina Cintia ↗Rawcliffe Adrian ↗

Which transactions qualify for the company tracker

The company strategy uses verified officers and directors with qualifying acquisitions at this issuer. Other reporting owners may appear in source records without becoming strategy signals.

Strategy eligibility is held while filing coverage is unresolved.

Historical follower simulations are separate from these source transactions. They do not establish live trading results.